Israel childhood vaccine schedule: 11 vaccines by age
For babies (first year): Hepatitis B, DTaP / Tdap, Polio (IPV), Hib, Pneumococcal (PCV), Rotavirus, MMR, Varicella (chickenpox), Hepatitis A. Click a vaccine for its Israel-specific page and its schedule in every other country.
| Vaccine | Status | Doses & recommended age |
|---|---|---|
| Hepatitis B · side effects & data | Universal | Dose 1 — At birth Dose 2 — 1 month Dose 3 — 6 months |
| DTaP / Tdap · side effects & data | Universal | Dose 1 — 2 months Dose 2 — 4 months Dose 3 — 6 months Dose 4 — 12 months Booster — 8 years |
| Polio (IPV) · side effects & data | Universal | Dose 1 — 2 months (IPV) Dose 2 — 4 months (IPV) Dose 3 — 6 months (IPV) Dose 4 — 12 months (IPV) Booster — 8 years (IPV) |
| Hib · side effects & data | Universal | Dose 1 — 2 months Dose 2 — 4 months Dose 3 — 6 months Dose 4 — 12 months |
| Pneumococcal (PCV) · side effects & data | Universal | Dose 1 — 2 months Dose 2 — 4 months Dose 3 — 6 months Booster — 12 months |
| Rotavirus · side effects & data | Universal | Dose 1 — 2 months (Rotavirus (oral)) Dose 2 — 4 months (Rotavirus (oral)) Dose 3 — 6 months (Rotavirus (oral)) |
| MMR · side effects & data | Universal | Dose 1 — 12 months (MMR or MMRV) Dose 2 — 6 years (MMR or MMRV) |
| Varicella (chickenpox) · side effects & data | Universal | Dose 1 — 12 months (MMRV) Dose 2 — 6 years (MMRV) |
| Hepatitis A · side effects & data | Universal | Dose 1 — 18 months Dose 2 — 24 months |
| HPV · side effects & data | Universal | Dose 1 — 13-14 years Dose 2 — 6 months after dose 1 |
| Influenza (flu) · side effects & data | Universal | Annual — 6 months-5 years and risk groups, every season |
Israel vaccine schedule vs. the United States
Israel and the United States share 11 routine vaccines. The U.S. routinely gives Meningococcal, COVID-19, which Israel does not.
| Vaccine | Israel first dose | U.S. first dose | Doses |
|---|---|---|---|
| Hepatitis B | At birth | Birth | 3 vs 3 doses |
| DTaP / Tdap | 2 months | 2 months | 5 vs 5 doses |
| Polio (IPV) | 2 months | 2 months | 5 vs 4 doses |
| Hib | 2 months | 2 months | 4 vs 4 doses |
| Pneumococcal (PCV) | 2 months | 2 months | 4 vs 4 doses |
| Rotavirus | 2 months | 2 months | 3 vs 3 doses |
| MMR | 12 months | 12-15 months | 2 vs 2 doses |
| Varicella (chickenpox) | 12 months | 12-15 months | 2 vs 2 doses |
| Hepatitis A | 18 months | 12-23 months | 2 vs 2 doses |
| HPV | 13-14 years | 11-12 years | 2 vs 2 doses |
| Influenza (flu) | 6 months-5 years and risk groups, every season | 6 months and older, every season | 1 vs 1 doses |
In the routine U.S. schedule but not Israel's: Meningococcal, COVID-19.
Why Israel's schedule looks the way it does
Schedules differ mostly because disease burden and health-system conditions differ. WHO/UNICEF estimates of how many children actually receive each vaccine, and the diseases' reported incidence, explain most of the choices below.
- Tuberculosis: 2.4 new cases per 100,000 people per year (2024). BCG is given only to risk groups (e.g. children with TB exposure or from high-incidence families). BCG mainly protects young children from severe TB (meningitis, miliary TB), so countries with high TB incidence give it at birth and low-incidence countries reserve it for risk groups.
- Measles: 0 reported cases per million people (2022). Two-dose coverage is 92%; sustained elimination needs roughly 95% coverage with both doses, which is why schedules add or move the second dose when coverage or outbreaks change.
- Hepatitis B birth dose: 95% coverage. A birth dose matters most where mothers commonly carry hepatitis B, because infection at birth becomes chronic in most infants; countries with low carriage and universal prenatal screening often start hepatitis B vaccination later or target only exposed newborns.
Coverage: share of children who received each vaccine (WHO/UNICEF estimates)
| Vaccine | Israel | United States |
|---|---|---|
| BCG (TB) | 68% (1982, old estimate) | not reported |
| DTP dose 1 | 99% (2025) | 98% (2025) |
| DTP dose 3 | 98% (2025) | 94% (2025) |
| Measles dose 1 | 98% (2025) | 92% (2025) |
| Measles dose 2 | 92% (2025) | 95% (2025) |
| Polio (IPV series) | 98% (2025) | 93% (2025) |
| Hep B birth dose | 95% (2025) | 75% (2025) |
| Hep B dose 3 | 96% (2025) | 93% (2025) |
| Hib dose 3 | 98% (2025) | 92% (2025) |
| Pneumococcal (PCV) | 94% (2025) | 84% (2025) |
| Rotavirus (complete) | 80% (2025) | 77% (2025) |
| HPV dose 1, girls | 51% (2025) | 73% (2025) |
Source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and WHO reported incidence, via the WHO Immunization Data portal; TB incidence from the WHO Global Health Observatory (indicator MDG_0000000020). Retrieved 2026-10-09. "Not reported" usually means the vaccine is not in the universal schedule. Polio is the completed inactivated-polio series (IPVC).